                </a></li></ul></div><p><strong>Figure 3.  <span>Surface Molecule Characterization of human SCAP.</span></strong></p><a id="article1.body1.sec2.sec1.fig3.caption1.p1" name="article1.body1.sec2.sec1.fig3.caption1.p1"></a><p>(<strong>A</strong>) Flow cytometric analysis of cultured SCAP at passage 1 revealed expression of STRO-1 (18.12%), CD146 (72.3%), CD24 (7.56%), CD166 (93.74%), CD73 (94.14%), CD90 (95.54%), CD105 (9.23%), CD106 (32.7%), CD29 (88.1%) and ALP (11.43%), but was negative for surface molecules CD18, CD14, CD34, CD45, and CD 150.</p>
<a id="article1.body1.sec2.sec1.fig3.caption1.p2" name="article1.body1.sec2.sec1.fig3.caption1.p2"></a><p>(<strong>B</strong>) After 2 weeks osteo-induction <em>in vitro</em> with L-ascorbate-2-phosphate, dexamethasone, and inorganic phosphate, SCAP differentiated into odontoblasts with a decrease in CD24 expression from 7.56% to 0.22%.</p>
<a id="article1.body1.sec2.sec1.fig3.caption1.p3" name="article1.body1.sec2.sec1.fig3.caption1.p3"></a><p>In contrast, ALP expression increased significantly from 11.43% to 86.59%.</p>
<span>THISISTHEEND
